During initial contract negotiation with the Commission, ESTOOLS reserved a portion of the project budget for tasks that may be carried out by a new contractor joining the consortium at a later date to be selected by means of a competitive call. ESTOOLS has now received and is evaluating several proposals. No new proposals can be accepted.
ESTOOLS aims to advance the fundamental knowledge that will underpin
biomedical application of human embryonic stem cells by developing
tools and procedures to facilitate (1) unlimited expansion of hESCs (2)
creation of techniques for the efficient, regulatable expression and
ablation of hESC gene function (3) directed differentiation of hESCs
into mature neural cell types exhibiting full phenotypic fidelity.
ESTOOLS wishes to enhance data storage and data analysis in the consortium with links to external datasets. A substantial amount of gene expression data will be generated and collated, primarily from Illumina gene chips but also from other microarray platforms and sequencing based approaches.
The role in the project of the new partner, which may be an SME, will be to undertake the following tasks:
Based on the above tasks ESTOOLS will negotiate with the successful proposer the detailed milestones and deliverables that will form part of the revised contract with the Commission.
The following expertise and experience would qualify the proposer as a potential new participant in the ESTOOLS consortium:
Funding available is up to Euro 300,000.
Information about the ESTOOLS project partners is available on this page.
The ESTOOLS project completed its 4 years of activity. This website remains online as a reference archive.
For hESC and iPSC news and information go to: www.eurostemcell.org